Pioglitazone and Glimepiride (Duetact)
Pioglitazone and Glimepiride stimulates insulin release from the pancreas to lower blood sugar.
Questions a plan sponsor actually asks.
What is Pioglitazone and Glimepiride used for?
Pioglitazone and Glimepiride stimulates insulin release from the pancreas to lower blood sugar.
Is there a generic for Pioglitazone and Glimepiride?
Yes. 2 ANDAs filed at FDA, 1 generic manufacturers currently shipping.
How much does my plan pay for Pioglitazone and Glimepiride?
Across 329 Part D plans, Pioglitazone and Glimepiride averages $10.61/unit (NADAC). Lowest available: $10.46/unit. Highest in distribution: $10.76/unit.
Is Pioglitazone and Glimepiride on the FDA shortage list?
No. Pioglitazone and Glimepiride is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (4 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.